Viewing Study NCT01581203


Ignite Creation Date: 2025-12-24 @ 7:14 PM
Ignite Modification Date: 2025-12-29 @ 8:22 AM
Study NCT ID: NCT01581203
Status: COMPLETED
Last Update Posted: 2015-10-09
First Post: 2012-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module